Company Filing History:
2 out of 445 
2 out of 8 Years Active: 2021-2025
Title: Yesseinia Anglero-Rodriguez: Innovator in RNAi Technology
Introduction
Yesseinia Anglero-Rodriguez is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) technologies aimed at combating viral infections.
Latest Patents
Yesseinia holds two notable patents related to coronavirus. The first patent, titled "Coronavirus IRNA compositions and methods of use thereof," focuses on RNAi agents, specifically double-stranded RNA (dsRNA) agents that target the coronavirus genome. This invention outlines methods for using these RNAi agents to inhibit the expression of the coronavirus genome and to treat or prevent diseases associated with the virus. The second patent, "Coronavirus iRNA compositions and methods of use thereof," shares similar objectives and methodologies, emphasizing the importance of RNAi agents in addressing coronavirus-related health issues.
Career Highlights
Throughout his career, Yesseinia has worked with leading biotechnology companies, including Alnylam Pharmaceuticals, Inc. and Vir Biotechnology, Inc. His work in these organizations has contributed to advancements in therapeutic strategies against viral infections.
Collaborations
Yesseinia has collaborated with notable professionals in the field, including Akin Akinc and James D McIninch. These partnerships have fostered innovation and development in RNAi technologies.
Conclusion
Yesseinia Anglero-Rodriguez is a key figure in the advancement of RNAi technology, particularly in the fight against coronavirus. His patents and collaborations reflect his commitment to improving public health through innovative solutions.